BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26202943)

  • 1. Comparative Pharmacophore Modeling and QSAR Studies for Structural Requirements of some Substituted 2-Aminopyridine Derivatives as Inhibitors of Nitric Oxide Synthases.
    Sharma MC
    Interdiscip Sci; 2015 Jun; 7(2):100-12. PubMed ID: 26202943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative pharmacophore modeling and QSAR studies for structural requirements of some substituted 2-aminopyridines derivatives as inhibitors nitric oxide synthases.
    Sharma MC
    Interdiscip Sci; 2014 Sep; ():. PubMed ID: 25183347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Structure-Activity Relationship Study of Naphthoquinone Derivatives as Antitubercular Agents Using Molecular Modeling Techniques.
    Sharma MC
    Interdiscip Sci; 2015 Dec; 7(4):346-56. PubMed ID: 26159131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of Potent Antihypertensive Ligands Substituted Imidazolyl Biphenyl Sulfonylureas Analogs as Angiotensin II AT1 Receptor Antagonists by Molecular Modelling Studies.
    Sharma MC
    Interdiscip Sci; 2015 Sep; 7(3):221-32. PubMed ID: 26188391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Structure-Activity Relationship Study of Imidazole-5-Carboxylic Acid Derivatives as Angiotensin II Receptor Antagonists Combining 2D and 3D QSAR Methods.
    Sharma MC
    Interdiscip Sci; 2016 Mar; 8(1):1-10. PubMed ID: 26202941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural requirements for inhibition of the neuronal nitric oxide synthase (NOS-I): 3D-QSAR analysis of 4-oxo- and 4-amino-pteridine-based inhibitors.
    Matter H; Kotsonis P; Klingler O; Strobel H; Fröhlich LG; Frey A; Pfleiderer W; Schmidt HH
    J Med Chem; 2002 Jul; 45(14):2923-41. PubMed ID: 12086480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QSAR studies on 3-(4-biphenylmethyl) 4, 5-dihydro-4-oxo-3H-imidazo [4, 5-c] Pyridine derivatives as angiotensin II (AT1) receptor antagonist.
    Sharma MC
    Interdiscip Sci; 2015 Jun; 7(2):113-28. PubMed ID: 26215494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of 3-Nitro-2,4,6-trihydroxybenzamide Derivatives as Photosynthetic Electron Transport Inhibitors by QSAR and Pharmacophore Studies.
    Sharma MC
    Interdiscip Sci; 2016 Jun; 8(2):109-21. PubMed ID: 26245276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QSAR modeling and in silico design of small-molecule inhibitors targeting the interaction between E3 ligase VHL and HIF-1α.
    Pan J; Zhang Y; Ran T; Xu A; Qiao X; Yin L; Zhou W; Zhu L; Zhao J; Lu T; Chen Y; Jiang Y
    Mol Divers; 2017 Aug; 21(3):719-739. PubMed ID: 28689235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation on Quantitative Structure Activity Relationships of a Series of Inducible Nitric Oxide.
    Sharma MC; Sharma S
    Interdiscip Sci; 2016 Dec; 8(4):346-351. PubMed ID: 27272764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective QSAR-Based Prediction Models with Pharmacophore Studies of Oxadiazole-Substituted α-Isopropoxy Phenylpropanoic Acids with Dual Activators of PPARα and PPARγ.
    Sharma MC
    Interdiscip Sci; 2015 Dec; 7(4):335-45. PubMed ID: 26178333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular modelling studies for the discovery of new substituted pyridines derivatives with angiotensin II AT1 receptor antagonists.
    Sharma MC
    Interdiscip Sci; 2014 Sep; 6(3):197-207. PubMed ID: 25205497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of B-Raf[Formula: see text] inhibitors using 2D and 3D-QSAR, molecular docking and pharmacophore studies.
    Aalizadeh R; Pourbasheer E; Ganjali MR
    Mol Divers; 2015 Nov; 19(4):915-30. PubMed ID: 26276566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural modification of 4, 5-dihydro-[1, 2, 4] triazolo [4, 3-f] pteridine derivatives as BRD4 inhibitors using 2D/3D-QSAR and molecular docking analysis.
    Tong JB; Luo D; Feng Y; Bian S; Zhang X; Wang TH
    Mol Divers; 2021 Aug; 25(3):1855-1872. PubMed ID: 33392965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QSAR studies on imidazopyrazine derivatives as Aurora A kinase inhibitors.
    Leng Y; Lu T; Yuan HL; Liu HC; Lu S; Zhang WW; Jiang YL; Chen YD
    SAR QSAR Environ Res; 2012 Oct; 23(7-8):705-30. PubMed ID: 22971111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insight into the Structural Determinants of Imidazole Scaffold-Based Derivatives as TNF-α Release Inhibitors by in Silico Explorations.
    Wang Y; Wu M; Ai C; Wang Y
    Int J Mol Sci; 2015 Aug; 16(9):20118-38. PubMed ID: 26307982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D-QSAR studies of some tetrasubstituted pyrazoles as COX-II inhibitors.
    Gupta GK; Kumar A
    Acta Pol Pharm; 2012; 69(4):763-72. PubMed ID: 22876620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved 3D-QSAR prediction by multiple-conformational alignment: A case study on PTP1B inhibitors.
    Zhang X; Mao J; Li W; Koike K; Wang J
    Comput Biol Chem; 2019 Dec; 83():107134. PubMed ID: 31629257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D-QSAR, molecular dynamics simulations, and molecular docking studies on pyridoaminotropanes and tetrahydroquinazoline as mTOR inhibitors.
    Chaube U; Bhatt H
    Mol Divers; 2017 Aug; 21(3):741-759. PubMed ID: 28577112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substituted 2-aminopyridines as inhibitors of nitric oxide synthases.
    Hagmann WK; Caldwell CG; Chen P; Durette PL; Esser CK; Lanza TJ; Kopka IE; Guthikonda R; Shah SK; MacCoss M; Chabin RM; Fletcher D; Grant SK; Green BG; Humes JL; Kelly TM; Luell S; Meurer R; Moore V; Pacholok SG; Pavia T; Williams HR; Wong KK
    Bioorg Med Chem Lett; 2000 Sep; 10(17):1975-8. PubMed ID: 10987430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.